This was the stock's third consecutive day of losses.
DXC Technology Co. closed 28.51% below its 52-week high of $24.83, which the company achieved on November 8th.
Marketers and their teams doing business as usual, while dabbling with different tools and dashboards, will not be enough to ...
DXC Technology (DXC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. Key Insights DXC Technology's estimated fair value is US$28.05 ...
Beckman Coulter Diagnostics announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer, ...
Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the new DxC 500i Clinical Analyzer, an ...
1d
Zacks Investment Research on MSNHere's Why DXC Technology Company. (DXC) is a Strong Value StockIt doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
The DxC 500i combines advanced technology with an intuitive user interface, ensuring that laboratories of all sizes can meet the growing demands of modern healthcare. With throughput of up to 800 ...
In a report released yesterday, Daniel Perlin from RBC Capital maintained a Hold rating on Rocket Companies (RKT – Research Report), with a ...
1d
The Slovak Spectator on MSNSlovakia’s business service centres seek talent in IT, finance and AIEven though the number of people working in business and shared service centres in Slovakia declined slightly last year, the ...
3d
Medical Device Network on MSNFDA clears Beckman Coulter’s DxC 500i Clinical AnalyzerThe US Food and Drug Administration (FDA) has granted 510(k) clearance to Beckman Coulter Diagnostics' new DxC 500i Clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results